Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male rat urinary bladder

Samuel Monroe Cohen, E. M. Garland, M. Cano, M. K. St John, M. Khachab, J. M. Wehner, Lora L Arnold

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Sodium saccharin administered at high doses to male rats beginning after 5 weeks of age produces mild urothelial hyperplasia but does not result in a significant increase in incidence of bladder cancer unless it is administered after an initiating agent. However, if it is administered in a two-generation bioassay, a significant incidence of bladder tumors is produced. The hyperplastic and tumorigenic effects are inhibited by co-administration with high doses of NH4C1. The present experiment was designed to evaluate the effects of another sodium salt, sodium ascorbate, administered through the neonatal time period. Sodium saccharin administered as 5% of the diet produced urothelial hyperplasia and increased labeling index, and this was inhibited by co-administration with 1.23% NH4CI. Four doses of sodium ascorbate were evaluated. The lowest dose, 0.91%, was without effect on the urinary tract. A slight effect (not statistically significant) was observed at a dose of 2.73%, and a significant proliferative response was detected at 4.56 and 6.84%. Recent studies suggest that a calcium phosphate-containing amorphous precipitate forms in the urine of rats fed high doses of sodium saccharin, producing cytotoxicity of the urothelium and consequent regenerative hyperplasia. This precipitate was observed in the present experiment in the rats administered the high dose of sodium saccharin or the higher doses of sodium ascorbate. Formation of this precipitate and induction of urothelial proliferation were inhibited by co-administration of NH4Cl, but somewhat higher doses of ammonium chloride were required for doses of sodium ascorbate compared to sodium saccharin. These results demonstrate that sodium ascorbate administered through the neonatal time period of the male rat produces urothelial hyperplasia in a dose responsive manner, with a no-effect level of 0.91% of the diet. The formation of the calcium phosphate-containing amorphous precipitate and urothelial proliferation were inhibited by co-administration with NH4Cl.

Original languageEnglish (US)
Pages (from-to)2743-2750
Number of pages8
JournalCarcinogenesis
Volume16
Issue number11
DOIs
StatePublished - Nov 1 1995

Fingerprint

Saccharin
Ammonium Chloride
Sodium Chloride
Ascorbic Acid
Urinary Bladder
Hyperplasia
Urinary Bladder Neoplasms
Diet
Urothelium
Incidence
Urinary Tract
Biological Assay
Salts
Sodium
Urine

ASJC Scopus subject areas

  • Cancer Research

Cite this

Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male rat urinary bladder. / Cohen, Samuel Monroe; Garland, E. M.; Cano, M.; St John, M. K.; Khachab, M.; Wehner, J. M.; Arnold, Lora L.

In: Carcinogenesis, Vol. 16, No. 11, 01.11.1995, p. 2743-2750.

Research output: Contribution to journalArticle

Cohen, Samuel Monroe ; Garland, E. M. ; Cano, M. ; St John, M. K. ; Khachab, M. ; Wehner, J. M. ; Arnold, Lora L. / Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male rat urinary bladder. In: Carcinogenesis. 1995 ; Vol. 16, No. 11. pp. 2743-2750.
@article{49947d6f5a844eefa413d1e15c6d3b08,
title = "Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male rat urinary bladder",
abstract = "Sodium saccharin administered at high doses to male rats beginning after 5 weeks of age produces mild urothelial hyperplasia but does not result in a significant increase in incidence of bladder cancer unless it is administered after an initiating agent. However, if it is administered in a two-generation bioassay, a significant incidence of bladder tumors is produced. The hyperplastic and tumorigenic effects are inhibited by co-administration with high doses of NH4C1. The present experiment was designed to evaluate the effects of another sodium salt, sodium ascorbate, administered through the neonatal time period. Sodium saccharin administered as 5{\%} of the diet produced urothelial hyperplasia and increased labeling index, and this was inhibited by co-administration with 1.23{\%} NH4CI. Four doses of sodium ascorbate were evaluated. The lowest dose, 0.91{\%}, was without effect on the urinary tract. A slight effect (not statistically significant) was observed at a dose of 2.73{\%}, and a significant proliferative response was detected at 4.56 and 6.84{\%}. Recent studies suggest that a calcium phosphate-containing amorphous precipitate forms in the urine of rats fed high doses of sodium saccharin, producing cytotoxicity of the urothelium and consequent regenerative hyperplasia. This precipitate was observed in the present experiment in the rats administered the high dose of sodium saccharin or the higher doses of sodium ascorbate. Formation of this precipitate and induction of urothelial proliferation were inhibited by co-administration of NH4Cl, but somewhat higher doses of ammonium chloride were required for doses of sodium ascorbate compared to sodium saccharin. These results demonstrate that sodium ascorbate administered through the neonatal time period of the male rat produces urothelial hyperplasia in a dose responsive manner, with a no-effect level of 0.91{\%} of the diet. The formation of the calcium phosphate-containing amorphous precipitate and urothelial proliferation were inhibited by co-administration with NH4Cl.",
author = "Cohen, {Samuel Monroe} and Garland, {E. M.} and M. Cano and {St John}, {M. K.} and M. Khachab and Wehner, {J. M.} and Arnold, {Lora L}",
year = "1995",
month = "11",
day = "1",
doi = "10.1093/carcin/16.11.2743",
language = "English (US)",
volume = "16",
pages = "2743--2750",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Effects of sodium ascorbate, sodium saccharin and ammonium chloride on the male rat urinary bladder

AU - Cohen, Samuel Monroe

AU - Garland, E. M.

AU - Cano, M.

AU - St John, M. K.

AU - Khachab, M.

AU - Wehner, J. M.

AU - Arnold, Lora L

PY - 1995/11/1

Y1 - 1995/11/1

N2 - Sodium saccharin administered at high doses to male rats beginning after 5 weeks of age produces mild urothelial hyperplasia but does not result in a significant increase in incidence of bladder cancer unless it is administered after an initiating agent. However, if it is administered in a two-generation bioassay, a significant incidence of bladder tumors is produced. The hyperplastic and tumorigenic effects are inhibited by co-administration with high doses of NH4C1. The present experiment was designed to evaluate the effects of another sodium salt, sodium ascorbate, administered through the neonatal time period. Sodium saccharin administered as 5% of the diet produced urothelial hyperplasia and increased labeling index, and this was inhibited by co-administration with 1.23% NH4CI. Four doses of sodium ascorbate were evaluated. The lowest dose, 0.91%, was without effect on the urinary tract. A slight effect (not statistically significant) was observed at a dose of 2.73%, and a significant proliferative response was detected at 4.56 and 6.84%. Recent studies suggest that a calcium phosphate-containing amorphous precipitate forms in the urine of rats fed high doses of sodium saccharin, producing cytotoxicity of the urothelium and consequent regenerative hyperplasia. This precipitate was observed in the present experiment in the rats administered the high dose of sodium saccharin or the higher doses of sodium ascorbate. Formation of this precipitate and induction of urothelial proliferation were inhibited by co-administration of NH4Cl, but somewhat higher doses of ammonium chloride were required for doses of sodium ascorbate compared to sodium saccharin. These results demonstrate that sodium ascorbate administered through the neonatal time period of the male rat produces urothelial hyperplasia in a dose responsive manner, with a no-effect level of 0.91% of the diet. The formation of the calcium phosphate-containing amorphous precipitate and urothelial proliferation were inhibited by co-administration with NH4Cl.

AB - Sodium saccharin administered at high doses to male rats beginning after 5 weeks of age produces mild urothelial hyperplasia but does not result in a significant increase in incidence of bladder cancer unless it is administered after an initiating agent. However, if it is administered in a two-generation bioassay, a significant incidence of bladder tumors is produced. The hyperplastic and tumorigenic effects are inhibited by co-administration with high doses of NH4C1. The present experiment was designed to evaluate the effects of another sodium salt, sodium ascorbate, administered through the neonatal time period. Sodium saccharin administered as 5% of the diet produced urothelial hyperplasia and increased labeling index, and this was inhibited by co-administration with 1.23% NH4CI. Four doses of sodium ascorbate were evaluated. The lowest dose, 0.91%, was without effect on the urinary tract. A slight effect (not statistically significant) was observed at a dose of 2.73%, and a significant proliferative response was detected at 4.56 and 6.84%. Recent studies suggest that a calcium phosphate-containing amorphous precipitate forms in the urine of rats fed high doses of sodium saccharin, producing cytotoxicity of the urothelium and consequent regenerative hyperplasia. This precipitate was observed in the present experiment in the rats administered the high dose of sodium saccharin or the higher doses of sodium ascorbate. Formation of this precipitate and induction of urothelial proliferation were inhibited by co-administration of NH4Cl, but somewhat higher doses of ammonium chloride were required for doses of sodium ascorbate compared to sodium saccharin. These results demonstrate that sodium ascorbate administered through the neonatal time period of the male rat produces urothelial hyperplasia in a dose responsive manner, with a no-effect level of 0.91% of the diet. The formation of the calcium phosphate-containing amorphous precipitate and urothelial proliferation were inhibited by co-administration with NH4Cl.

UR - http://www.scopus.com/inward/record.url?scp=0028869153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028869153&partnerID=8YFLogxK

U2 - 10.1093/carcin/16.11.2743

DO - 10.1093/carcin/16.11.2743

M3 - Article

C2 - 7586194

AN - SCOPUS:0028869153

VL - 16

SP - 2743

EP - 2750

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 11

ER -